Lygature LIVE 2026: Two Decades of Collaboration, Looking Ahead to Tomorrow’s Health

ExpediteBio Joins Oncode Accelerator as New Partner in the Biologics Workstream

Doderm: Six Years of Advancing Skin Health Through Natural Immune Care

Building Blocks of High-Performing Organizations: Competence

National investment agenda aims to position the Netherlands as a global leader in industrial biotechnology

Kostenefficiënt puzzelen met gebruikers

Europa heeft de wetenschap. Nu is het tijd voor een strategie.

A new chapter for transplant diagnostics: CareDx Lab Products join GenDx

ExpediteBio and AVS Bio Partner to Enable Fully Integrated Developability Driven Antibody Development and Manufacturing

NIZO food research and Winclove Probiotics join forces in strategic partnership built on interdependency and microbial innovation

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

After the Bench: What the BioBusiness Summer School 2026 Taught Me

MindCapture and Strand join forces to shape the future of life sciences in Belgium

TargED Raises €40.4M Series A2 to Advance First-in-Class Targeted Thrombolytic TGD001

Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease

Alturos Therapeutics advancement of lead candidate

Product naar patiënt. Het kan sneller. Het kan beter.

Zo pakt Noord-Nederland het groeiende tekort aan mensen en kennis in Life Sciences & Health aan

Confo Therapeutics Announces Encouraging Preclinical Data for Post-bariatric Hypoglycemia Candidate CFTX-2034 at ENDO 2026

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis

Leading Without Limits: A Woman’s Journey in Biotech Leadership